News | May 23, 2024
Merck to acquire life science company Mirus Bio for US$ 600 million
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Establishing Asymchem’s first manufacturing footprint in Europe
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Lupin updates on shipment of Mirabegron ER Tablets
The company is committed to address this observation comprehensively within stipulated time
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The proposed facility is expected to be operational around January, 2027
Subscribe To Our Newsletter & Stay Updated
